Fundraising Fox

Frontier Medicines

South San Francisco, US · Founded 2018 · Delaware corporation · 81 employees on LinkedIn · 10 known investors

Find your way into Frontier Medicines

277 people in our graph share verified history with the Frontier Medicines team — schools, employers, funds. One of them is your warm intro.

Logan Hilleunlockedknows Chris Varma · together at Harvard Medical School (overlapped)
×4knows the team · via Harvard Medical School
×7knows the team · via MPM BioImpact

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.

AI & Machine LearningBiotech

Founders & leadership

Frontier Medicines was founded in 2018 by Chris Varma, Ph.D. and Chris Varma.

CVChris Varma, Ph.D.
Chris Varma, Ph.D.Co-founderManaging Partner at MPM BioImpact
CVChris Varma
Chris VarmainCo-founder, Chairman and CEOChris Varma co-founded Blueprint Medicines (acquired by Sanofi) and Warp Drive Bio (acquired by Revolution Medicines), and has held senior roles at venture capital firms Flagship Pioneering, Third Rock Ventures, and MPM Capital. He holds a Ph.D. from Harvard-MIT's HST program in machine learning and cancer biology, as well as advanced degrees in computer science and management from Stanford.
JW
Jim WinklerExecutive
JHJohannes Hermann, Ph.D.
Johannes Hermann, Ph.D.Executive
KWKevin Webster
Kevin WebsterinChief Science Officer
GC
Gregory ChowExecutive

Board

JNJanwillem Naesens
Janwillem NaesensBoard directorManaging Partner at Droia Ventures
CW
Cameron WheelerinBoard directorPartner at Deerfield Management Company
LELuke Evnin
Luke Evninin𝕏Board directorAdvisor at MPM BioImpact
OLOthman Laraki
Othman LarakiinBoard MemberExecutive Officer, Director at Color Genomics

Investors · 10

Berkeley CatalystBerkeley
DCVC (Data Collective)Palo Alto · $5M – $25M
Droia VenturesLeuven · $540K
MPM BioImpactBoston · $1M – $15M
RA CapitalBoston
DCVC BioreportedPalo Alto
Deerfield Management CompanyreportedNew York

Also in the syndicate · 3

DeerfieldGalapagosGalapagos NV

Funding

SEC filings, press & company announcements

$235.5M disclosed across 3 of 5 rounds · 2019–2025

▶$88.5MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim WinklerExecutive Officer
  • Janwillem NaesensDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Kevin WebsterExecutive Officer
  • Cameron WheelerDirector
  • Luke EvninDirector
  • Gregory ChowExecutive Officer
  • Chris Varma, Ph.D.Executive Officer, Director
  • Othman LarakiDirector
Offering amount
$88.5M
Amount sold
$88.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$67MraisedNov 2020 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris Varma, Ph.D.Executive Officer, Director
  • Luke EvninDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Othman LarakiDirector
  • Janwillem NaesensDirector
  • Cameron WheelerDirector
  • Jim WinklerExecutive Officer
  • Kevin WebsterExecutive Officer
Offering amount
$67M
Amount sold
$67M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Frontier Medicines went on to found or lead other companies.

Luke EvninDirectorFounded Mpmcapital +1Kristina NebelSenior Executive AssistantFounded Walking Fish Therapeutics

Competitors · 2

by search overlap
Bioworld32 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Eli Lilly26 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies competing with Frontier Medicines for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline | Frontier Medicinesfrontiermeds.com · Aug 2025Frontier Medicines Raises $80M in Series C Funding | Precision Medicine Onlineprecisionmedicineonline.com · Feb 2024Frontier Medicines Raises $80M in Series C, Targets Amgen and BMS in KRAS - BioSpacebiospace.com · Feb 2024Frontier CEO weathers 'hardest financing' ever to raise $80Mfiercebiotech.com · Feb 2024Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program - BioSpacebiospace.com · Jul 2021Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipelineglobenewswire.com · Jul 2021Deerfield x Frontier Medicines – studying investment decisionsaxial.substack.com · Feb 2020

Frequently asked questions

What does Frontier Medicines do?
Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.
Who founded Frontier Medicines?
Frontier Medicines was founded by Chris Varma, Ph.D., Chris Varma in 2018.
Who are Frontier Medicines's investors?
Frontier Medicines's investors include Berkeley Catalyst, DCVC (Data Collective), Droia Ventures, MPM BioImpact, RA Capital, DCVC Bio, Deerfield Management Company.
How much funding has Frontier Medicines raised?
Frontier Medicines has disclosed $235.5M raised across 3 of its 5 known rounds.
Where is Frontier Medicines headquartered?
Frontier Medicines is headquartered in South San Francisco, US.